BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
LEP
,
Angiogenesis
,
Arthritis
,
Endothelial cell
,
Early pregnancy factor
,
Aspirin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
4-vinylcyclohexene diepoxide
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SOX4
SCD
ZFAND5
MALAT1
EPB41L2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
MARTINEZ_RB1_TARGETS_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Ovarian gene expression responses to xenobiotic insult
Explore Curated Studies Results
Literature
Most Relevant Literature
4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity.
Ovarian expressed microsomal epoxide hydrolase: role in detoxification of 4-vinylcyclohexene diepoxi…
7,12-dimethylbenz[a]anthracene induces sertoli-leydig-cell tumors in the follicle-depleted ovaries o…
Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice.
Glutathione S-transferase class μ regulation of apoptosis signal-regulating kinase 1 protein during …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for 4-vinylcyclohexene diepoxide
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ